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WHAT THIS PAPER ADDS
In the present study, two of six genetic variants located in TGFB1, TGFBR1, TGFBR2 and AGTR1 were identiﬁed as
potential risk factors for the presence of abdominal aortic aneurysms (AAAs) in a Chinese population. Moreover,
geneegene interaction between three polymorphisms and complex geneeenvironment interactions with
smoking, dyslipidemia and rs1800469 may affect AAA risk.
Objective/Background: Evidence has accumulated that multiple polymorphisms in the transforming growth
factor (TGF)-b pathway and renineangiotensin system play important roles in determining susceptibility to
abdominal aortic aneurysm (AAA). Few studies have considered interactions between these gene polymorphisms
and environmental factors. The aim of this study was to evaluate the contribution of single nucleotide
polymorphisms (SNPs) and complex geneeenvironment interactions in AAA.
Methods: Six SNPs located in TGFB, TGFBR1, TGFBR2 and AGTR1 were selected. Genotyping of blood samples and
collection of lifestyle factors were performed in 155 unrelated participants with AAAs and 310 non-AAA controls.
Unconditional logistic regression was performed to assess the effects of SNPs on the risk of AAA. Generalized
multifactor dimensionality reduction (GMDR) was used to evaluate geneegene and geneeenvironment
interactions.
Results: Participants carrying TGFB1 rs1800469 TT (odds ratio [OR] 1.83, 95% conﬁdence interval [CI] 1.18e2.85)
or AGTR1 rs12695895 TT (OR 4.21, 95% CI 1.41e12.53) genotypes had a higher risk of AAA than those with the
common CC genotype. The geneegene interaction of AGTR1 rs5182, TGFBR1 rs1626340, and TGFB1 rs1800469
was found to be the best model according to the results of the GMDR analysis (cross validation consistency
[CVC]) 10/10; p ¼ .010). Smoking, dyslipidemia, and rs1800469 together contributed to the risk of AAA, which
demonstrated a potential and complex geneeenvironment interaction among the three variants that might
affect AAA risk (CVC 6/10; p ¼ .001).
Conclusion: In this study of the Chinese population, homozygosity of TGFB1 rs1800469-T and AGTR1 rs12695895-
T might be associated with increased risk of AAA. The complex geneegene and geneeenvironment interactions
might contribute to the risk of AAA. As a small study, the preliminary results need extensive validation and
replication in larger populations.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Abdominal aortic aneurysm (AAA) is characterized by
segmental weakening and dilation of the aortic wall.
Several environmental factors, such as age, male sex, and
smoking, are implicated in the formation of AAA.1 The
disease is also recognized to have a strong genetic
component. Five chromosomal loci in the human genome
have been identiﬁed via genome-wide association studies
as genetic risk factors for AAA, including CDKN2BAS
c These authors contributed equally to the work presented here and
should therefore be considered equivalent authors.rs10757278, CNTN3 rs7635818, DAB2IP rs7025486, LRP1
rs1466565, and LDLR rs6511720.2e6 Moreover, AAA sus-
ceptibility genes based on candidate gene analysis have
been described as MMP3 5A/6A (rs3025058), ACE I/D
(rs4646994), AGTR1 1166A/C (rs5186), MTHFR 677C/T
(rs1801133), SORT1(rs599839), and IL6R rs7529229.5,7e15
However, previously identiﬁed genetic loci explain only a
portion of the contribution of genetic effect. There are
also many factors related to heterogeneity, and it is
difﬁcult to identify the mechanism of a disease from an
isolated study of the association between a single risk
factor and the complex disease. How geneegene and
72 Trans-Atlantic Debategeneeenvironment interactions lead to AAA is poorly
understood and will likely to play a critical role in the
future understanding of this disease.16
The transforming growth factor (TGF)-b family has been
shown to regulate alternative pathways that can cause
matrix degradation. Biros et al. performed a meta-analysis
based on three case control groups,17 and they concluded
that several genetic variations of TGFBR1 and TGFBR2 were
associated with AAA. However, Morris et al. failed to detect
the relationship between genetic polymorphisms in the
main receptors for TGF-b and AAA.7 Therefore, the role of
TGF-b in the development of AAA in genetic epidemiology
is controversial.
Angiotensin II is the ﬁnal effector of the renineangio-
tensin system (RAS), through the activation of AGTR1.
Angiotensin II acts to increase TGF-b mRNA levels, which
can alter wall stress due to inﬂammation and proteoly-
sis.18 However, the interaction between AGTR1 and TGF-b
pathway-related genetic polymorphisms in AAA is not
clear.
Herein, a preliminary caseecontrol study was performed
to explore whether any genetic variants of TGFB1, TGFBR1,
TGFBR2, and AGTR1, and their geneegene or geneeenvi-
ronment interactions contributed to AAA formation in a
Chinese Han population.
MATERIALS AND METHODS
Study site and population
Details of this case control study design, methods, and
participants have been described previously.19 Patients
with AAAs (n ¼ 155) who were diagnosed at the Vascular
and Endovascular Surgery Department of the Chinese PLA
General Hospital, were enrolled. Patients with AAAs
selected for the study were diagnosed with infrarenal AAA
by computed tomography (CT) and were ready to undergo
elective repair surgery. Half (n ¼ 155) of the control par-
ticipants were from the Vascular and Endovascular Surgery
Department of the Chinese PLA General Hospital, and half
(n ¼ 155) were from communities in Beijing. Control
participants were sex and age matched (within 5 years)
with patients with AAAs and were excluded if they had an
AAA by abdominal Doppler ultrasound test. Patients with
AAAs and controls were excluded if they had a serious
inﬂammatory process that might inﬂuence the predictive
value of biochemical testing, had any mental disorders, or
were pregnant. The study was conducted with the
approval of the ethics committee of Chinese PLA General
Hospital. Written informed consent was obtained from
each participant.
Data collection procedures
Using a standardized questionnaire to collect data related to
social demographic information, history of chronic diseases,
and lifestyle factors, an interview was conducted with each
participant. A history of chronic disease among all partici-
pants included hypertension, hyperlipidemia, type 2diabetes, coronary artery disease (CAD), and peripheral
arterial disease (PAD). Smoking, alcohol consumption, and
leisure activities were recorded as lifestyle factors. Partici-
pants were divided into two groups according to smoking
status (those who never smoked and smokers), alcohol use
(none to almost none and drinkers), and frequency of lei-
sure activity (none to almost none and at least 1 day/week).
Participants underwent a standard physical examination
including body temperature, blood pressure, and abdominal
ultrasound or CT. The maximum diameter of each AAA was
measured from a conventional CT scan after vascular sur-
geons reviewed the entire scan. AAA was deﬁned as a
maximal infrarenal aortic diameter 30 mm. To exclude
AAA, two trained physicians performed abdominal ultra-
sound examinations for control group participants. After the
entire scan from renal artery level to the bifurcation of
aorta had been reviewed, the maximum inner to inner
diameter of the abdominal aorta was measured in the
transverse view between the renal artery level and 1 cm
distal to it.20 Peripheral venous fasting blood samples were
obtained in order to evaluate biochemical parameters and
to extract DNA from leukocytes. Biochemical parameters
were analyzed at the clinical laboratory of PLA General
Hospital, Beijing, China.
Single nucleotide polymorphism selection and genotyping
of polymorphisms
Genomic DNA was extracted from peripheral blood using
salt fractionation and stored at 80 C. Single nucleotide
polymorphisms (SNPs) of AGTR1 and TGF-b pathway related
genes were chosen based on their functional relevance and
importance. These SNPs were in the promoter regions or
had been associated with cardiovascular diseases.21 SNPs
from four genes were assessed, including rs1800469 of
TGFB1, rs1626340 of TGFBR1, rs3773643 and rs4522809 of
TGFBR2, and rs5182 and rs12695895 of AGTR1. A poly-
merase chain reaction was performed using an Applied
Biosystems GeneAmp 9700 384 Dual thermal cycler
(Applied Biosystems, Foster City, CA, USA). Genotypes were
analyzed using Typer 4.0 software (Mass ARRAY Compact
System; Sequenom, San Diego, CA, USA).
Statistical analysis
Comparisons of continuous variables (age, education years,
and abdominal aortic diameter) between patients and
controls were performed using the non-parametric Manne
Whitney test. HardyeWeinberg equilibrium for each SNP in
participants in the control group was tested using a chi-
square test. The rare allele was deﬁned as the less
frequent allele in unaffected participants, also called the
minor allele. Using the chi-square test, each minor allele
frequency of patients with AAAs was compared with those
of the controls. The dominant, recessive, and additive ge-
netic models were used for analysis. Unconditioned logistic
regression of genetic models on AAA was performed and
odds ratios (ORs) and 95% conﬁdence intervals (CIs) for AAA
risk were estimated for the six SNPs. All statistical analyses
Table 1. Demographic and clinical characteristics of patients with abdominal aortic aneurysms and control participants.
Characteristic Case group (n ¼ 155) Control group (n ¼ 310) Chi-square (F) p
Age, yr (mean  SD) 69.2  9.9 69.5  9.9 0.12 .73
Sex (male) 138 (89.0) 276 (89.0) 0.00 1.00
Married (yes) 138 (89.0) 265 (85.5) 0.55 .45
Years of education (mean  SD) 10.1  5.1 7.0  4.8 37.81 <.001
Smoking habits (yes) 132 (85.2) 167 (53.9) 39.58 <.001
Drinking habits (yes) 79 (51.0) 125 (40.3) 4.73 .03
Physical activity habits (yes) 94 (60.6) 195 (62.9) 0.10 .64
Hypertension (yes) 108 (69.7) 143 (46.1) 22.39 <.001
Dyslipidemia (yes) 118 (76.1) 138 (44.5) 25.42 <.001
Type-2 diabetes (yes) 18 (11.6) 46 (14.8) 0.91 .34
CAD (yes) 53 (34.2) 80 (25.8) 3.52 .06
PAD (yes) 51 (32.9) 51 (16.5) 15.80 <.001
Abdominal aorta diameter, mm (mean  SD) 54.2  16.1 17.0  3.2 17.0 <.001
Note. Data are given as n (%) unless otherwise indicated. CAD ¼ coronary artery disease; PAD ¼ peripheral arterial disease.
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Cary, NC, USA). Permutation tests (number of
permutations ¼ 10,000) were performed as a measure of
signiﬁcance corrected for multiple testing bias via PLINK
software (http://pngu.mgh.harvard.edu/wpurcell/plink/) to
calculate the corrected probabilities of genetic association
between groups.22,23 Statistical tests were considered to be
signiﬁcant at an alpha level of .05 in a two-tailed test.
Statistical power was calculated using the PS: Power and
Sample Size Calculation v3.0 (http://biostat.mc.vanderbilt.
edu/wiki/Main/PowerSampleSize).
Generalized multifactor dimensionality reduction (GMDR;
version 0.7, obtained from http://www.medicine.virginia.
edu/clinical/departments/psychiatry/sections/
neurobiologicalstudies/genomics/gmdr-software-request)
was applied to analyze geneegene and geneeenvironment
interactions. The GMDR method is described in detail
elsewhere.24 Brieﬂy, the simplest model with the maximum
cross validation consistency (CVC) and the sign test, which is
a non-parametric test with a p-value of .05 or lower, was
considered as the best interaction model. A total of 1,000
permutations were used to determine the statistical sig-
niﬁcance of the best model.Table 2. Gene variants observed in patients with abdominal aortic a
Gene dbSNP AAA group (n ¼ 155)
Genotype frequency (%) MAFa
TGFB1 rs1800469 TT (31.2) CT (45.5) CC (23.4) T ¼ 5
TGFBR1 rs1626340 AA (24.2) GA (51.6) GG (24.2) A ¼
TGFBR2 rs3773643 GG (5.9) GA (30.9) AA (63.2) G ¼
TGFBR2 rs4522809 CC (8.1) CT (43.9) TT (48.0) C ¼ 3
AGTR1 rs5182 CC (9.0) CT (46.5) TT (44.5) C ¼ 3
AGTR1 rs12695895 TT (6.5) TC (16.8) CC (76.8) T ¼ 1
Note. dbSNP ¼ Single Nucleotide Polymorphism database; MAF ¼ m
a MAF in case and control groups.
b Allele distributions were compared between AAA and control grou
c pcorr is the corrected probabilities of allelic association estimated bRESULTS
Characteristics of participants
The study included a total of 465 participants. The de-
mographic and clinical characteristics of the participants are
given in Table 1. A total of 155 patients (138 men; 89.0%)
with AAAs were enrolled and the mean abdominal aortic
diameter was 54.2  16.1 mm. The mean age of patients
with AAAs was 69.2  9.9 years. Statistically signiﬁcant
differences were found for traditional cardiovascular risk
factors, including smoking habits, drinking habits, hyper-
tension, dyslipidemia, and PAD. The presence of type 2
diabetes and CAD were not signiﬁcantly different between
the groups (p > .05).
SNP analysis
The available sample sizes of 155 AAA cases and 310 con-
trols had >60% and 85% power to detect ORs ofw1.5 and
w1.8, respectively, for the association of risk alleles with
AAA (Supplementary Appendix I). None of the SNPs showed
signiﬁcant deviation from HardyeWeinberg equilibrium.
The genotype and minor allele frequencies of TGFB1
rs1800469; TGFBR1 rs1626340; TGFBR2 rs3773643,
rs4522809; and AGTR1 rs5182, rs12695895 and their asso-
ciation with AAA risk are shown in Table 2. After permu-
tation tests, the allele frequencies did not differ between
the case and control groups (pcorr > .05). Individualsneurysms (AAAs) and controls.
Control group (n ¼ 310) pb pcorrc
Genotype frequency (%) MAF
4.0 TT (19.7) CT (52.9) CC (27.4) T ¼ 46.2 .01 .16
50.0 AA (23.6) GA (45.5) GG (31.0) A ¼ 46.4 .29 .88
21.4 GG (6.5) GA (33.3) AA (60.2) G ¼ 23.2 .55 .99
0.1 CC (7.2) CT (44.3) TT (48.5) C ¼ 29.4 .82 1.00
2.3 CC (7.7) CT (40.0) TT (52.3) C ¼ 27.7 .15 .65
4.9 TT (1.6) TC (18.1) CC (80.3) T ¼ 10.7 .07 .36
inor allele frequency.
ps by chi-square analysis, and p-values reported.
y permutation test with PLINK (number of permutations ¼ 10,000).
Table 3. Association between abdominal aortic aneurysms and polymorphisms in dominant, recessive, and additive models.
Gene dbSNP Minor
allelea
Dominant modelb Recessive model Additive model
OR (95% CI)c p pcorr
d
OR (95% CI) p pcorr OR (95% CI) p pcorr
TGFB1 rs1800469 T 1.21 (0.77e1.88) 0.41 0.91 1.83 (1.18e2.85) .007 .03 1.35 (1.03e1.78) .03 .11
TGFBR1 rs1626340 A 1.33 (0.86e2.06) 0.19 0.52 1.02 (0.65e1.60) .94 1.00 1.12 (0.86e1.47) .39 .84
TGFBR2 rs3773643 G 0.86 (0.58e1.28) 0.46 0.98 0.89 (0.40e2.01) .79 1.00 0.89 (0.65e1.23) .48 1.00
TGFBR2 rs4522809 C 0.95 (0.65e1.40) 0.79 1.00 1.10 (0.53e2.28) .80 1.00 0.98 (0.72e1.34) .92 1.00
AGTR1 rs5182 C 1.36 (0.93e2.01) 0.12 0.51 1.18 (0.59e2.36) .63 1.00 1.25 (0.92e1.68) .15 .84
AGTR1 rs12695895 T 1.24 (0.78e1.97) 0.38 0.93 4.21 (1.41e12.53) .01 .02 1.39 (0.95e2.01) .09 .10
Note. dbSNP ¼ Single Nucleotide Polymorphism database; OR ¼ odds ratio; CI ¼ conﬁdence interval.
a The minor allele was deﬁned as the less frequent allele in unaffected participants. Groups of major allele homozygous participants were
deﬁned as referent groups in genetic models.
b The dominant model compares individuals with one or two minor alleles with the group of homozygous participants. The recessive
model compares individuals with two minor alleles with the combined group of heterozygous and major allele homozygous participants.
The additive model assumes that there is a linear gradient in risk between the three genotypes.
c Logistic regressions of genotypes were performed and ORs, 95% CIs, and p-values estimated.
d pcorr is the corrected probabilities of genotype association estimated by permutation test with PLINK (number of permutations¼ 10,000).
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higher likelihood of AAA than the CC genotype in the
recessive model (OR 1.83, 95% CI 1.18e2.85) (Table 3). This
suggested that carriers of the rs1800469 TT genotype were
more likely to develop an AAA than those with the CC ge-
notype. Homozygosity of AGTR1 rs12695895-T, which was
the rare allele, also increased the likelihood of developing
an AAA (OR 4.21, 95% CI 1.41e12.53) in the recessive ge-
netic model (Table 3). Other SNP genotypes did not in-
crease AAA risk in any of the three genetic models tested.
Geneegene interactions
GMDR was performed to explore the geneegene in-
teractions of six genetic polymorphisms. Moreover, to
decrease confounding from other factors, demographic
factors, such as age, sex, marital status, and years of edu-
cation, were adjusted. Table 4 shows the results for two
factor to six factor models adjusted by covariates, as
mentioned above. The three factor interaction model of
AGTR1 rs5182, TGFBR1 rs1626340, and TGFB1 rs1800469
was the best geneegene interaction model identiﬁed. It
had a maximum CVC of 10/10, the maximum testing bal-
ance accuracy (0.61), and a sign test p-value of .01. These
ﬁndings suggested the interaction of rs1800469, rs1626340,





2 rs1800469, rs1626340 0.5
3 rs1800469, rs1626340, rs5182 0.6
4 rs1800469, rs1626340, rs5182, rs4522809 0.7
5 rs1800469, rs1626340, rs5182, rs4522809,
rs3773643
0.7
6 rs1800469, rs1626340, rs5182, rs4522809,
rs3773643, rs12695895
0.8
Note. CVC ¼ cross-validation consistency.
a Adjusted by covariates, including age, sex, marital status, and yeaGeneeenvironment interactions
GMDR was used to assess the contribution of combinations
of environmental factors and genetic polymorphisms to the
risk of AAA. Possible environmental risk factors, including
smoking, drinking, physical exercise habits, hypertension,
dyslipidemia, type 2 diabetes, CAD, PAD, and the six SNPs,
were brought into the interaction model. The results of
geneeenvironment interactions on AAA risk for two factor
to six factor models adjusted by covariates are presented in
Table 5. The potential interaction of smoking and dyslipi-
demia on AAA risk was discovered (CVC ¼ 10/10; p < .001)
and the best geneeenvironment interaction was the model
of smoking, dyslipidemia, and TGFB1 rs1800469 (CVC ¼ 6/
10; sign test p-value ¼ .001). This indicated a potential
geneeenvironment interaction among the three variants
affecting AAA risk.
DISCUSSION
AAA is a multifactorial disease inﬂuenced by complex ge-
netic and environmental factors. In this study, the associa-
tion of AGTR1 and TGF-b-related genetic polymorphisms,
and their geneegene and geneeenvironment interactions
in a Chinese Han population, were evaluated.
Six common variants of TGFB1, TGFBR1, TGFBR2, and
AGTR1 were investigated. Allele frequencies of these SNPs









9 0.48 8/10 3 (.95) .29
5 0.61 10/10 9 (.01) .001
1 0.59 9/10 9 (.01) .002
7 0.59 10/10 6 (.38) .011
1 0.58 10/10 8 (.05) .031
rs of education.












2 Smoking, dyslipidemia 0.73 0.72 10/10 10 (.001) <.001
3 Smoking, dyslipidemia, rs1800469 0.73 0.70 6/10 10 (.001) <.001
4 Smoking, dyslipidemia, physical exercise,
rs3773643
0.75 0.66 3/10 9 (.01) .001
5 Smoking, rs1800469, rs1626340,rs5182,
rs4522809
0.79 0.62 4/10 10 (.001) <.001
6 Dyslipidemia, hypertension, rs1800469,
rs1626340, rs5182, rs4522809
0.85 0.60 3/10 8 (.05) .031
Note. CVC ¼ cross-validation consistency.
a Adjusted by covariates including age, sex, marital status, and years of education.
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with other ethnic groups (Supplementary Appendix II).
These results demonstrate that, when evaluating a disease
related gene, owing to genetic heterogeneity, it is necessary
to study the genetic associations in different ethnic groups.
TGFB1 rs1800469 is in the promoter region and appears
to inﬂuence the regulation of TGF-b1 plasma levels.
rs1800469 has been reported to be associated with car-
diovascular diseases.25 However, genetic associations be-
tween rs1800469 and AAA are still confounding. Only
Thompson et al. demonstrated that a rare rs1800469 ho-
mozygote was associated with the presence of AAA in a UK
cohort.26 However, this association was lost after adjusting
for confounders.
AGTR1 rs12695895 is located in an intronic region. Few
studies have evaluated the role of rs12695895 in cardio-
vascular diseases. Only Nie et al. have reported rs12695895
to be associated with essential hypertension in a Han Chi-
nese population.27 The present study found that homozy-
gosity of rs12695895-T could increase the likelihood of
developing AAA. However, there is a need for further
research to better characterize their exact association.
AGTR1 rs5182 is located in an exonic region and its variation
might inﬂuence the normal progress of microRNA tran-
scription, leading to altered AGTR1 expression.28 The pre-
sent study failed to ﬁnd an association between rs5182 and
AAA. In the participants in the present study, the frequency
of rs5182-C was exactly the same as that of the general
Chinese population (27.9% vs. 27.7%).29 In contrast, rs5182-
C was present in 44% of white people.30 Therefore, one
possible explanation for the differences in the results might
be ethnic variations.
TGF-b and RAS play an essential role in matrix deposition
and extracellular cell matrix (ECM) degradation. An inter-
action between TGF-b and RAS related genes had been
found that they could inﬂuence the development of AAA.21
In the present study, the effect of the interaction of rs5182,
rs1626340, and rs1800469 on AAA were also estimated,
suggesting close and complicated correlations exist be-
tween the TGF-b family and AGTR1. Angiotensin II could
increase TGF-b mRNA expression and regulate TGF-b serum
levels. In addition, polymorphisms in TGFB1 could corre-
spond to reduced levels of TGF-b and angiotensin II.31Therefore, the interaction between TGF-b and the RAS
pathway is close and complicated. The correlation between
genes and biological mechanisms of AAA require further
study.
The GMDR analysis demonstrated that TGFB1 rs1800469,
smoking, and dyslipidemia potentially worked together in
affecting AAA risk. Smoking and dyslipidemia are strong risk
factors for AAA and are thought to contribute to the initi-
ation and progression of vascular ﬁbrosis. TGF-b plays a
critical role in ECM accumulation and vascular remodeling
by upregulating ﬁbroblast growth factor expression and
participating in the ﬁbrotic process.32 These ﬁndings sug-
gested that smoking, dyslipidemia, and the TGF-b pathway
might inﬂuence AAA formation via the vascular ﬁbrotic
process, but the speciﬁc process is unknown.
There were several limitations to this study that warrant
consideration. First, the sample size was small. It was found
that the available sample sizes of 155 AAA cases and 310
controls had >60% and 85% statistical power to detect ORs
of w1.5 and w1.8, respectively, for the association of the
risk alleles with AAA. Therefore, the results should be
considered preliminary and requiring veriﬁcation. Second,
the number of SNPs genotyped was limited. Only six poly-
morphisms were chosen and one geneeenvironment
interaction affecting AAA risk discovered. However, several
factors that inﬂuenced the presence of AAA, such as type 2
diabetes, hypertension, and atherosclerotic diseases, were
not discovered to have potential interactions with AAA risk,
warranting a more comprehensive study of complex in-
teractions in AAA.
CONCLUSION
This study is the ﬁrst to report that TGFB1 rs1800469 and
AGTR1 rs12695895 genetic polymorphisms might be asso-
ciated with AAA risk in a Chinese Han population.
Furthermore, complex interactions between environmental
factors and polymorphisms might contribute to the risk of
AAA. Owing to small sample size, the results should be
considered preliminary and requiring extensive validation
and replication in larger populations.
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